follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

PTC Therapeutics appoints chief commercial officer

By

Back to Top Comments Email Print

Latest News

advertisement

South Plainfield-based PTC Therapeutics, Inc. announced Tuesday the appointment of Mark A. Rothera as chief commercial officer, responsible for global commercial functions supporting PTC's pipeline, including the investigational new drug ataluren.

A veteran of the orphan drug arena, Mr. Rothera has spent 15 of his 23 years in the biopharmaceutical industry, according to a release. He served previously as global president of Aegerion Pharmaceuticals Inc.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top